애스크로AIPublic Preview
← 학술논문 검색
학술논문Nuclear Medicine and Molecular Imaging2009.02 발행KCI 피인용 1

Kasabach-Merritt 증후군을 동반한 거대 간 혈관종: Tc-99m 적혈구 간 및 전신 혈액풀 신티그래피와 SPECT소견

A Giant Hepatic Hemangioma Complicated by Kasabach-Merritt Syndrome: Findings of Tc-99m RBC Scintigraphy and SPECT Including a Total Body Blood Pool Imaging Study

손명희(전북대학교); 정환정(전북대학교); 임석태(전북대학교); 김동욱(전북대학교); 임창열(전북대학교)

43권 1호, 83~86쪽

초록

Kasabach-Merritt syndrome (KMS) consists of thrombocytopenia, microangiopathic hemolytic anemia, and localized consumption coagulopathy that develops within vascular hemangioma. This syndrome may also be associated with occult hemangiomas located at various sites. Tc-99m RBC scintigraphy and SPECT have proven to be reliable for confirming or excluding hemangioma. Total body blood pool imaging study during the scintigraphy also provides a means of screening for occult lesions. The authors report the case of a 29-year-old man who presented with a giant hepatic hemangioma complicated by KMS, and underwent Tc-99m RBC scintigraphy and SPECT including a total body blood pool imaging study.

Abstract

Kasabach-Merritt syndrome (KMS) consists of thrombocytopenia, microangiopathic hemolytic anemia, and localized consumption coagulopathy that develops within vascular hemangioma. This syndrome may also be associated with occult hemangiomas located at various sites. Tc-99m RBC scintigraphy and SPECT have proven to be reliable for confirming or excluding hemangioma. Total body blood pool imaging study during the scintigraphy also provides a means of screening for occult lesions. The authors report the case of a 29-year-old man who presented with a giant hepatic hemangioma complicated by KMS, and underwent Tc-99m RBC scintigraphy and SPECT including a total body blood pool imaging study.

발행기관:
대한핵의학회
분류:
핵의학

AI 법률 상담

이 논문의 주제에 대해 더 알고 싶으신가요?

460만+ 법률 자료에서 관련 판례·법령·해석례를 찾아 답변합니다

AI 상담 시작
Kasabach-Merritt 증후군을 동반한 거대 간 혈관종: Tc-99m 적혈구 간 및 전신 혈액풀 신티그래피와 SPECT소견 | Nuclear Medicine and Molecular Imaging 2009 | AskLaw | 애스크로 AI